Stay updated on Efficacy of Orally Administered DS107 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Orally Administered DS107 in Atopic Dermatitis Clinical Trial page.

Latest updates to the Efficacy of Orally Administered DS107 in Atopic Dermatitis Clinical Trial page
- Check5 days agoChange DetectedSite revision updated: Revision v3.3.4 was added and Revision v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedLocations section reorganized to consolidate site listings under a single Locations heading with state subsections (Alabama, California, District of Columbia, Florida, Georgia, Illinois, Kentucky, Michigan, North Carolina, Oregon, Pennsylvania, Texas, Utah, Virginia, Wisconsin). Revision updated to v3.3.3.SummaryDifference1%

- Check55 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing Revision: v3.2.0.SummaryDifference0.0%

- Check62 days agoChange Detected- Removed the government funding status notice banner from the page.SummaryDifference0.3%

- Check76 days agoChange DetectedNo notable additions or deletions were observed between the two screenshots of the Study Details page for NCT03817190.SummaryDifference0.3%

- Check105 days agoChange DetectedCore content updated to v3.2.0 with a government-operating-status notice and a removal of the previous v3.1.0 marker.SummaryDifference2%

Stay in the know with updates to Efficacy of Orally Administered DS107 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Orally Administered DS107 in Atopic Dermatitis Clinical Trial page.